Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus documentMarieke Biegstraaten, Carla E. M. Hollak, Tarekegn Geberhiwot et al.|Orphanet Journal of Rare Diseases|2015Cited by 345
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic responseNick Dekker, Johannes M. F. G. Aerts, Anna Tylki‐Szymańska et al.|Blood|2011Cited by 288
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare diseaseMaurizio Scarpa, J. E. Wraith, Gunilla Malm et al.|Orphanet Journal of Rare Diseases|2011Cited by 231
Skeletal and Bone Mineral Density Features, Genetic Profile in Congenital Disorders of Glycosylation: ReviewPatryk Lipiński, Aleksandra Jezela‐Stanek, Karolina M. Stępień et al.|Diagnostics|2021Cited by 24